These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7783258)

  • 1. [Neuron-specific enolase: a serum marker of clinical progression for metastatic malignant melanoma].
    Guo HB; Stoffel-Wagner B; Brennemann W; Springer W; Klingmüller D
    J Tongji Med Univ; 1995; 15(1):19-25. PubMed ID: 7783258
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuron-specific enolase as a prognostic factor in metastatic malignant melanoma.
    Wibe E; Hannisdal E; Paus E; Aamdal S
    Eur J Cancer; 1992; 28A(10):1692-5. PubMed ID: 1389487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuron-specific enolase as a tumor marker in metastatic melanoma.
    Buzaid AC; Sandler AB; Hayden CL; Scinto J; Poo WJ; Clark MB; Hotchkiss S
    Am J Clin Oncol; 1994 Oct; 17(5):430-1. PubMed ID: 8092117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of serum S100 in metastatic malignant melanoma.
    Guo HB; Stoffel-Wagner B; Bierwirth T; Mezger J; Klingmüller D
    Eur J Cancer; 1995 Oct; 31A(11):1898-902. PubMed ID: 8541129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuron-specific enolase--a serum marker for malignant melanoma.
    Lorenz J; Dippold W
    J Natl Cancer Inst; 1989 Nov; 81(22):1754-5. PubMed ID: 2810389
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuron specific enolase (NSE) in serum of patients with malignant melanoma.
    Wibe E; Paus E; Aamdal S
    Cancer Lett; 1990 Jun; 52(1):29-31. PubMed ID: 2354416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum neuron-specific enolase in metastatic Merkel cell tumors.
    Giannone L; Johnson DH; Grosh WW; Davis BW; Marangos PJ; Greco FA
    Med Pediatr Oncol; 1985; 13(6):357-62. PubMed ID: 3900664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuron-specific enolase (NSE)--a suitable tumor marker in malignant melanoma?].
    Hornef S; Lux J; Rassner G
    Hautarzt; 1992 Feb; 43(2):77-80. PubMed ID: 1347764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuron-specific enolase as serum marker for malignant melanoma.
    Couvreur R; Joos G; Geerts ML; Lambert J; Naeyaert JM
    Lancet; 1993 Oct; 342(8877):985. PubMed ID: 8105228
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum marker for Merkel cell tumour.
    Plowman PN
    Clin Radiol; 1989 Sep; 40(5):542. PubMed ID: 2619805
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuron-specific enolase--a serum tumour marker in seminoma?
    Fosså SD; Klepp O; Paus E
    Br J Cancer; 1992 Feb; 65(2):297-9. PubMed ID: 1739633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-100 and NSE as serum markers in melanoma.
    Tofani A; Cioffi RP; Sciuto R; Rea S; Festa A; Di Filippo F; Cavaliere R; Maini CL
    Acta Oncol; 1997; 36(7):761-4. PubMed ID: 9490097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum neuron-specific enolase (NSE) as a tumour marker for the Ewing's sarcoma family of tumours.
    Fizazi K; Le Cesne A; Dohollou N; Affaied S; Spielmann M; Le Chevalier T
    Eur J Cancer; 1996 Sep; 32A(10):1823-4. PubMed ID: 8983301
    [No Abstract]   [Full Text] [Related]  

  • 14. A new standard of care for metastatic melanoma?
    Sharma SP
    Lancet Oncol; 2015 Jan; 16(1):e8. PubMed ID: 25638559
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum neuron-specific enolase as a tumor marker in the diagnosis and follow-up of small-cell lung cancer.
    Pinson P; Joos G; Watripont P; Brusselle G; Pauwels R
    Respiration; 1997; 64(1):102-7. PubMed ID: 9044484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of serum S100 in metastatic malignant melanoma.
    Guo HB; Stoffel-Wagner B; Bierwirth T; Mezger J; Klingmüller D
    Eur J Cancer; 1995 Jun; 31A(6):924-8. PubMed ID: 7646923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuron-specific enolase and beta 2-microglobulin in the serum of patients with melanoma].
    Uerlich M; Biltz H; Kreysel HW
    Immun Infekt; 1988 Apr; 16(2):65-7. PubMed ID: 3292403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum matrix metalloproteinase-2 as a prognostic marker in advanced cutaneous melanoma.
    Vuoristo MS; Kellokumpu-Lehtinen P; Parvinen LM; Hahka-Kemppinen M; Korpela M; Kumpulainen E; Laine S
    Acta Oncol; 2000; 39(7):877-9. PubMed ID: 11145448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum neuron-specific enolase as a marker of small-cell carcinoma of the esophagus.
    Sasajima K; Watanabe M; Ando T; Hao K; Miyashita M; Yamashita K; Onda M; Takubo K
    J Clin Gastroenterol; 1990 Aug; 12(4):384-8. PubMed ID: 2168912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment serum level of neuron specific enolase (NSE) as a prognostic factor in metastatic prostate cancer patients treated with endocrine therapy.
    Kamiya N; Akakura K; Suzuki H; Isshiki S; Komiya A; Ueda T; Ito H
    Eur Urol; 2003 Sep; 44(3):309-14; discussion 314. PubMed ID: 12932928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.